AnxietyMar 15, 2026
Up to half of people who show up to an emergency room or cardiology clinic with low-risk or non-cardiac chest pain have significant anxiety or a diagnosable anxiety disorder. That number is striking. But here's the part most people get wrong: the relationship between anxiety and chest pain isn't a one-way street. Prospective data from people with coronary heart disease show that chest pain strongly increases later anxiety and depression, while anxiety only modestly predicts future chest pain, and mainly in the short term. The two feed each other, but chest pain is the more powerful driver.
None of this means anxiety chest pain isn't real. It is. It can feel identical to heart pain, and it sends people to the ER repeatedly. But understanding which direction the cycle runs changes how you think about fixing it.
AnxietyMar 15, 2026
Fluoxetine (brand name Prozac) can meaningfully reduce anxiety across several disorders, but if you're an adult with generalized anxiety, it's likely not the first medication your prescriber will reach for. Network meta-analyses place duloxetine, pregabalin, venlafaxine, and escitalopram ahead of fluoxetine for generalized anxiety disorder (GAD), not because Prozac doesn't work, but because those alternatives have stronger and larger bodies of evidence behind them.
That said, fluoxetine has two areas where its evidence is genuinely strong: pediatric anxiety and panic disorder. If you or your child falls into one of those categories, the research tells a more compelling story. The picture is nuanced, and where fluoxetine fits depends heavily on who's taking it and what they're taking it for.
Respiratory HealthMar 15, 2026
Carbon dioxide isn't just a waste gas you exhale. When levels drop too low in your arterial blood, your brain's blood vessels constrict, oxygen delivery to tissues falls, and in critically ill patients, the risk of death goes up. The medical term is hypocapnia: an arterial CO₂ level (PaCO₂) below roughly 35 mmHg, almost always caused by breathing faster or deeper than your body needs.
Most of the time, a mild and temporary drop in CO₂ is harmless. But in hospitals, operating rooms, and emergency settings, low CO₂ is consistently linked to worse outcomes. The research makes a strong case that keeping CO₂ in a normal range (about 35 to 45 mmHg) matters more than many people realize.
AnxietyMar 15, 2026
Gabapentin prescriptions for anxiety are climbing, but there's a disconnect between how often it's prescribed and what the evidence actually supports. For generalized anxiety disorder, the condition most people think of when they hear "anxiety," there are zero randomized controlled trials. Not weak trials. Zero. The evidence that does exist is limited to case reports and small uncontrolled observations. Where gabapentin shows real promise is in narrower, more specific situations: social anxiety, pre-surgical nerves, and anxiety related to breast cancer treatment.
That gap between widespread use and thin evidence matters if you're considering this medication or already taking it. SSRIs, SNRIs, and cognitive behavioral therapy remain the standard first-line treatments for anxiety disorders, and gabapentin sits firmly in the off-label, second- or third-line category.
CortisolMar 15, 2026
The supplement aisle is packed with "adrenal support" products, but when you look at actual clinical trials measuring cortisol in human blood or saliva, the list shrinks fast. Ashwagandha is the only supplement with consistent, replicated evidence for lowering cortisol in stressed adults. Probiotics and vitamin C show real promise in specific situations, but beyond that trio, the data gets thin quickly.
That doesn't mean nothing else works. It means nothing else has been tested well enough to say with confidence. Here's what the research can and can't tell you right now.
MedicationsMar 15, 2026
For most people with depression, Lexapro (escitalopram) and Zoloft (sertraline) will work about equally well. Head-to-head trials comparing the two over 8 to 12 weeks consistently land in the same place: no major difference. But "about equally well" hides some genuinely useful nuance. Depending on the severity of your depression, your age, what else is going on with your health, and how sensitive you are to side effects, one of these drugs may be a clearly better fit than the other.
The broad strokes are simple. Both are SSRIs, both are considered first-line treatments, and both have low discontinuation rates in trials. The interesting part is where they diverge.
AnxietyMar 15, 2026
Propranolol does something very specific: it blocks the physical symptoms of anxiety. The pounding heart, the shaking hands, the visible sweat. What it doesn't reliably do is treat anxiety itself. When researchers pool the evidence, only 25% of findings clearly support propranolol for anxiety disorders, while 38% find it ineffective for that purpose. The remaining studies land somewhere in the middle. That split tells you something important about where this drug fits and where it doesn't.
The disconnect matters because propranolol prescriptions for anxiety have become common, even though the strongest evidence supports it only in narrow, short-term situations. Understanding exactly when it helps, when it doesn't, and when it might actually be dangerous can save you from leaning on a tool that isn't built for the job you need it to do.
StressMar 15, 2026
Ashwagandha gummies have become one of the most popular supplement formats on the market, promising help with stress, sleep, and focus in a candy-like package. If you've been curious about trying them, or you already have a jar on your nightstand, you probably want to know: do they actually work, and are they safe?
The short answer is that ashwagandha extract does have real evidence behind it for reducing stress, improving sleep, and sharpening certain aspects of thinking. But most of that evidence comes from capsules and powders, not gummies, and the gap between a clinical-grade extract and what's in a flavored chewable matters more than you might think. This article will walk you through what doses have been studied, what benefits you can reasonably expect, and the safety signal you should know about before you buy.
Blood HealthMar 15, 2026
Most people think of carbon dioxide as a waste gas, something your body just needs to get rid of. But when CO₂ drops too low in your blood, it triggers a chain reaction that constricts blood vessels in your brain and heart, shifts how oxygen binds to your red blood cells, and ultimately reduces oxygen delivery to the organs that need it most. Low blood CO₂ is not a minor lab quirk. It is repeatedly associated with worse outcomes in heart failure, brain injury, stroke, major surgery, and critical illness.
The normal range for arterial CO₂ (called PaCO₂) sits between 35 and 45 mmHg. Hypocapnia, the medical term for low CO₂, generally means a PaCO₂ below 35 mmHg. Whether it shows up on an arterial blood gas or as low bicarbonate on a routine metabolic panel, it almost always points to something that deserves attention.
StressMar 15, 2026
Most ashwagandha research studies capsules filled with standardized extracts, not the earthy cup of tea you might be brewing at home. But there's one detail buried in the science that makes the tea form genuinely interesting: water-based preparations capture triethylene glycol, a compound linked to non-REM sleep promotion in animal studies. Alcohol-rich withanolide extracts, the kind typically packed into supplement capsules, did not promote sleep in mice.
That distinction matters if sleep is the reason you're reaching for ashwagandha. It also introduces the central tension with ashwagandha tea: the traditional preparation might have a unique edge for sleep, but nearly all the clinical evidence we have comes from a different form entirely.
MedicationsMar 13, 2026
No clinical trials have found that taking Lexapro (escitalopram) at one time of day works better than another. Every major study for anxiety simply used once-daily dosing without specifying morning versus evening as important to how well the drug works. What the research does focus on, and what actually matters for your results, is getting the right dose, sticking with it long enough, and taking it consistently.
